Clinical Trials in New York

Showing 481-500 of 19,464 trials

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

NCT06941480

The purpose of this study is to find out whether 177Lu-DTPA-SC16.56 is a safe treatment for people with small-cell lung cancer or neuroendocrine prostate cancer

Neuroendocrine Tumor of the LungNeuroendocrine Carcinoma of LungNeuroendocrine Carcinoma+1 more

Memorial Sloan Kettering Cancer Center12 participantsStarted Jun 2026

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +4 more locations

Not Yet RecruitingNA< 1 mile

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

NCT07225309

The purpose of this study is to find out if Meaning-Centered Psychotherapy for Latinos (MCP-L) helps reduce anxiety and depression and improves quality of life compared to cognitive behavioral therapy (CBT). Investigators also want to learn what participants and providers think about the therapy, including how the therapy is designed, outside factors, available resources, and how the people involved affect how well MCP-L works.

Breast CancerProstate CancerColorectal Cancer+9 more

Memorial Sloan Kettering Cancer Center300 participantsStarted Jun 2026

New York, New York, United States • Mexico City, Mexico

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Find Trials by Condition in New York

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

SIMPLAAFY Clinical Trial

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Retinoblastoma Phase II Expanded Access Clinical Trial

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Savolitinib vs. Sunitinib in MET-driven PRCC.

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

A Study of ZW251 in Participants With Advanced Solid Tumors

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia

N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma

Clinical Decision Support Tool in PARDS Pilot Study

A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis

A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD